AKRO Shares Outstanding History
Below is a table of the AKRO shares outstanding history going back to 8/12/2019:

Date AKRO Shares Outstanding
8/12/201928.56M
8/14/201932.72M
11/8/201928.56M
3/6/202028.61M
5/8/202028.67M
8/7/202034.70M
11/6/202034.72M
3/10/202134.77M
5/7/202134.83M
8/8/202134.86M
11/9/202134.89M
2/15/202235.01M
4/29/202235.02M
7/29/202237.57M

Also see: AKRO Market Cap History
AKRO YTD Return
AKRO Historical Shares Outstanding:
+9.70% CAGR
AKRO Historical Shares Outstanding: +9.70% CAGR

Mouse over chart for data details
8/12/2019 ...7/29/2022
Akero Therapeutics is a clinical-stage company developing treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. NASH is a severe form of nonalcoholic fatty liver disease characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, liver failure, cancer and death. Co.'s primary product candidate, efruxifermin, is an analog of fibroblast growth factor 21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates and proteins throughout the body. We show 14 historical shares outstanding datapoints in our coverage of AKRO's shares outstanding history.

Understanding the changing numbers of AKRO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AKRO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AKRO by allowing them to research AKRO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree AKRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Akero Therapeutics (AKRO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AKRX Shares Outstanding History
AKUS Shares Outstanding History
AKYA Shares Outstanding History
ALBO Shares Outstanding History
ALC Shares Outstanding History
ALDR Shares Outstanding History
ALDX Shares Outstanding History
ALEC Shares Outstanding History
ALGN Shares Outstanding History
ALGS Shares Outstanding History
More Healthcare companies »

 

AKRO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.